Want to see HK:2373 full AI Analyst Report?
2373 Stock Chart & Stats
HK$19.49
HK$0.10(0.53%)
At close: 4:00 PM EDT
HK$19.49
HK$0.10(0.53%)
Day’s Range― - ―
52-Week RangeHK$15.60 - HK$38.88
Previous CloseN/A
Volume0.00
Average Volume (3M)286.38K
Market Cap
HK$4.94B
Enterprise ValueHK$5.04K
Total Cash (Recent Filing)HK$2.41B
Total Debt (Recent Filing)HK$1.32B
Price to Earnings (P/E)10.5
Beta0.45
Next Earnings
Mar 31, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.66%
Share Statistics
EPS (TTM)1.60
Shares Outstanding251,593,720
10 Day Avg. Volume98,750
30 Day Avg. Volume286,376
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)5.54
Price to Sales (P/S)1.89
P/FCF Ratio6.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.67Price Target Upside62.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)1.75
Revenue Forecast (FY)HK$3.95B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthStrong multi-year revenue expansion, especially the 2025 step-up, indicates meaningful business growth and broader demand. If this trajectory persists, higher scale can support continued investment, reinforce market presence, and provide a durable foundation for earnings growth over the next several quarters.
Profitability ImprovementThe improvement in net and gross margins shows that recent growth has translated into better profitability, not just higher sales. Stronger margins can enhance internal cash generation and give the company greater resilience while supporting sustainable earnings progression.
Cash GenerationRising operating and free cash flow demonstrates that the business is converting operations into cash, an important support for funding expansion and meeting obligations. Good cash conversion can reduce reliance on external financing and strengthen the company’s ability to execute over time.
Bears Say
Higher LeverageThe sharp increase in debt relative to equity raises financial risk and reduces flexibility compared with prior years. Higher leverage can make the company more sensitive to operating setbacks and constrain future capital allocation, even though equity remains meaningful and returns on equity are strong.
Cash Flow UncertaintyReported coverage indicators of 0.0 and negative free-cash-flow growth create uncertainty about the consistency and quality of cash generation. This weakens confidence in year-over-year comparability and makes it harder to assess how reliably cash can support investment, debt service, and distributions.
Earnings VolatilityMargin volatility and the earlier 2022 revenue decline show that earnings power has not been perfectly steady. Although recent results improved, uneven historical performance increases the risk that profitability may fluctuate as operating conditions change, making long-term growth less predictable.
Beauty Farm Medical & Health Industry, Inc. News
2373 FAQ
What was Beauty Farm Medical & Health Industry, Inc.’s price range in the past 12 months?
Beauty Farm Medical & Health Industry, Inc. lowest stock price was HK$15.60 and its highest was HK$38.88 in the past 12 months.
What is Beauty Farm Medical & Health Industry, Inc.’s market cap?
Beauty Farm Medical & Health Industry, Inc.’s market cap is HK$4.94B.
When is Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date?
Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date is Mar 31, 2027 which is in 191 days.
How were Beauty Farm Medical & Health Industry, Inc.’s earnings last quarter?
Beauty Farm Medical & Health Industry, Inc. released its earnings results on Aug 27, 2026. The company reported HK$1.063 earnings per share for the quarter.
Is Beauty Farm Medical & Health Industry, Inc. overvalued?
According to Wall Street analysts Beauty Farm Medical & Health Industry, Inc.’s price is currently Undervalued.
Does Beauty Farm Medical & Health Industry, Inc. pay dividends?
Beauty Farm Medical & Health Industry, Inc. pays a Annually dividend of HK$0.72 which represents an annual dividend yield of 3.66%. See more information on Beauty Farm Medical & Health Industry, Inc. dividends here
What is Beauty Farm Medical & Health Industry, Inc.’s EPS estimate?
Beauty Farm Medical & Health Industry, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beauty Farm Medical & Health Industry, Inc. have?
Beauty Farm Medical & Health Industry, Inc. has 251,593,720 shares outstanding.
What happened to Beauty Farm Medical & Health Industry, Inc.’s price movement after its last earnings report?
Beauty Farm Medical & Health Industry, Inc. reported an EPS of HK$1.063 in its last earnings report. Following the earnings report the stock price went up 7.918%.
Which hedge fund is a major shareholder of Beauty Farm Medical & Health Industry, Inc.?
Currently, no hedge funds are holding shares in HK:2373
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Farm Medical & Health Industry, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$31.67 (62.49% Upside)
HK$31.67 (62.49% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.31%
12-Months-Change
Fundamentals
Return on Equity
3.66%
Trailing 12-Months
Asset Growth
23.50%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Beauty Farm Medical & Health Industry, Inc.
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
2373 Stock 12 Month Forecast
Average Price Target
HK$31.67
▲(62.49% Upside)
Technical Analysis
Raily Aesthetic Medicine International Holdings Limited
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―
UMP Healthcare Holdings Limited
―